Metabolic and health complications of obesity
- PMID: 2261844
Metabolic and health complications of obesity
Abstract
Overnutrition manifested by obesity has emerged as a major health problem in affluent countries. In spite of increased interest in fitness, obesity is on the increase in the United States. This is particularly so among children and adolescents. Although obesity is associated with many risk factors for diseases, the mechanisms whereby it enhances disease risk are not fully understood. Such an understanding is needed to develop strategies for management of these conditions. In this report we suggest that overnutrition produces clinical diseases only in individuals who already possess a metabolic weakness or "defect" in a given system. In the absence of such underlying defects, overnutrition, or obesity, is well tolerated. One of the most common consequences of obesity is dyslipidemia, that is, elevations of very low-density lipoprotein (VLDL) triglycerides and low-density lipoprotein (LDL) cholesterol and low concentrations of high-density lipoprotein (HDL) cholesterol. The major effect of overnutrition on lipoprotein metabolism is to stimulate the production of VLDL. For patients who have an underlying defect in lypolysis of VLDL triglycerides, hypertriglyceridemia will develop in the obese state. For those who have defective clearance of LDL, obesity will accentuate hypercholesterolemia. Both of these effects can be explained by overproduction of VLDL, due to obesity, combined with a genetic defect in clearance of VLDL or LDL. The mechanism whereby obesity causes a lowering of HDL cholesterol is uncertain, although it could enhance removal of HDL by an excess of adipose tissue. Another disease associated with obesity is cholesterol gallstones. The presence of obesity more than doubles the risk for gallstones. Two underlying factors increase the danger for gallstones: a deficiency of hepatic secretion of bile acids and a tendency for formation of cholesterol crystals in bile. Overnutrition promotes the synthesis of whole-body cholesterol, and the only route for excretion of this excess cholesterol is through the biliary tree.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Ischaemic heart disease as an effect of obesity-related metabolic disturbances.Cent Eur J Public Health. 1999 Aug;7(3):122-9. Cent Eur J Public Health. 1999. PMID: 10499142 Review.
-
[Effect of hypolipidemic treatment on the composition of bile and the risk or cholesterol gallstone disease].Cas Lek Cesk. 2007;146(1):24-34. Cas Lek Cesk. 2007. PMID: 17310581 Review. Czech.
-
Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.Dan Med Bull. 2002 Feb;49(1):43-60. Dan Med Bull. 2002. PMID: 11894723 Review.
-
Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.Can J Cardiol. 1997 Mar;13(3):253-60. Can J Cardiol. 1997. PMID: 9117913
-
Understanding and treating dyslipidemia associated with noninsulin-dependent diabetes mellitus and hypertension.Pharmacotherapy. 1993 Jul-Aug;13(4):340-52. Pharmacotherapy. 1993. PMID: 8361860 Review.
Cited by
-
CRISPR-Cas9-mediated generation of obese and diabetic mouse models.Exp Anim. 2018 May 10;67(2):229-237. doi: 10.1538/expanim.17-0123. Epub 2018 Jan 16. Exp Anim. 2018. PMID: 29343656 Free PMC article.
-
Therapy of gallstone disease: What it was, what it is, what it will be.World J Gastrointest Pharmacol Ther. 2012 Apr 6;3(2):7-20. doi: 10.4292/wjgpt.v3.i2.7. World J Gastrointest Pharmacol Ther. 2012. PMID: 22577615 Free PMC article.
-
Cholecystectomy and risk of metabolic syndrome.Eur J Intern Med. 2018 Jul;53:3-11. doi: 10.1016/j.ejim.2018.04.019. Epub 2018 Apr 26. Eur J Intern Med. 2018. PMID: 29706426 Free PMC article. Review.
-
Controlling Lipids AIDS in the Prevention of Type 2 Diabetes, Hypertension, and Cardiovascular Diseases.Int J Prev Med. 2017 Jun 1;8:39. doi: 10.4103/ijpvm.IJPVM_184_16. eCollection 2017. Int J Prev Med. 2017. PMID: 28656095 Free PMC article.
-
Long term effects of ketogenic diet in obese subjects with high cholesterol level.Mol Cell Biochem. 2006 Jun;286(1-2):1-9. doi: 10.1007/s11010-005-9001-x. Epub 2006 Apr 21. Mol Cell Biochem. 2006. PMID: 16652223 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical